Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care;Punto de corte óptimo de NT-proBNP para el diagnóstico de insuficiencia cardiaca mediante un test de determinación rápida en atención primaria

Revista Espanola de Cardiologia

Volumn 65, Issue 7, 2012, Pages 613-619

  Verdú, José M ^a,b   Comín Colet, Josep ^b,c   Domingo, Mar ^a   Lupón, Josep ^b,d   Gómez, Miguel ^b,c   Molina, Luis ^b,c   Casacuberta, Jose M ^a   Muñoz, Miguel A ^a,b   Mena, Amparo ^a   Bruguera Cortada, Jordi ^c  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Diagnosis; Heart failure; Natriuretic peptides; Primary care

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENERAL PRACTITIONER; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; POINT OF CARE TESTING; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; COMORBIDITY; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; ROC CURVE; VENTRICULAR DYSFUNCTION;

EID: 84862878878     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.01.019     Document Type: Article

References (22)

1. Hobbs F, Doust J, Mant J, Cowie M. Diagnosis of heart failure in primary care. Heart. 2010;96:1773-7.
2. Remes J, Miettinen H, Reunamen A, Pyraola K. Validity of clinical diagnosis of Heart failure in primary care. Eur Heart J. 1991;12:315-21.
3. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Truthers AD. Echocardiography in chronic heart failure in the community. Q J Med. 1993;86:17-23.
4. Khunti K. Systematic review of open access echocardiography for primary care. Eur J Heart Fail. 2004;6:79-83.
5. Collinson P. Determinación de péptido natriurético tipo B aminoterminal urinario en pacientes con insuficiencia cardiaca: ¿autopista o carretera secundaria? Rev Esp Cardiol. 2011;64:355-7.
6. Kim HN, Januzzi Jr JL. Natriuretic peptide testing in heart failure. Circulation. 2011;123:2015-9.
7. Baggish A, Van Kimmenade R, Januzzi J. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol. 2008;101 Suppl A:A43-8.
8. Januzzi JL, Van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP study. Eur Heart J. 2006;27:330-7.
9. Manzano-Fernández S, Januzzi JL, Boronat García M, Bonaque-González J, Muñoz-Esparza C, Albaladejo-Otón M, et al. Valor pronóstico comparativo del propéptido natriurético tipo B aminoterminal urinario en pacientes con insuficiencia cardiaca aguda descompensada. Rev Esp Cardiol. 2011;64: 365-72.
10. Barrios V, Llisterri JL, Escobar C, Alfaro P, Colado F, Ridocci F, et al. Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: the PANAMA study. Expert Rev Cardiovasc Ther. 2011;9:579-85.
11. Collinson PO. The cost effectiveness of B-type natriuretic peptide measurement in the primary care setting - a UK perspective. Congest Heart Fail. 2006;12: 103-7.
12. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;2539-50.
13. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole- Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J. 2008;29:2388-442.
14. National Clinical Guideline Centre. Chronic heart failure: the management of chronic heart failure in adults in primary and secondary care. Londres: National Clinical Guideline Centre; 2010. Disponible en: http://guidance.nice. org.uk/ CG108/Guidance/pdf/English
15. Hildebrandt P, Collinson P. Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients. Am J Cardiol. 2008;101 Suppl A:A25-8.
16. Hildebrandt P, Collinson P, Doughty R, Fuat A, Gaze D, Gustafsson F, et al. Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cutpoint for ruling out suspected systolic dysfunction in primary care. Eur Heart J. 2010;31:1881-9.
17. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol. 2003;42:1793-800.
18. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail. 2005;7:537-41.
19. Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract. 2006;56:327-33.
20. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail. 2005;11 Suppl 11:S15-20.
21. Goode KM, Clark Al, Cleland JG. Ruling out heart failure in primary care: the cost-benefit of pre-screening using NT pro-BNP and QRS width. Int J Cardiol. 2008;130:426-37.
22. Aspromonte N, Feola M, Scardovi AB, Coletta C, D'Eri A, Giovinazzo P, et al. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography. J Cardiovasc Med (Hagerstown). 2006;7:406-13.